Analysis of CNVs in the top-10 HCC cancer-related genes with focal CNVs showed a larger number of amplifications in MYC (4q12) in low AR-RNA patients (FDR = 0.07) (Supplementary Table S5). This evidence concerns the gene AR and hepatocellular carcinoma.